Literature DB >> 3340214

Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain.

U Nudel1, K Robzyk, D Yaffe.   

Abstract

Duchenne muscular dystrophy (DMD), a sex-linked degenerative disorder of the muscle, is one of the most common lethal genetic diseases in man. It affects about one male in 3,500, with an estimated one-third of cases being caused by new mutations. A less severe disease, Becker's muscular dystrophy (BMD), maps to the same chromosomal locus and is most probably an allelic form of DMD. Both diseases are sometimes associated with various degrees of mental retardation; the molecular basis of these phenotypes is unknown (for review, see ref. 1). The giant DMD gene spans approximately 2,000 kilobases (kb) (0.05% of the human genome) and encodes a 14-kb mRNA. The tissue-specificity of its expression has not been precisely determined. Monaco et al., using Northern blots, reported expression of the gene in human fetal skeletal muscle and small intestine but not in human fetal brain, or in human cultured myoblasts and transformed B and T cells. More recently, expression was detected in mouse skeletal and cardiac muscle, but not in mouse brain. Here we show, using a ribonuclease protection assay, that the DMD gene is developmentally regulated in rat and mouse myogenic cell cultures, and that it is expressed in rat and mouse striated muscle, in mouse smooth muscle and in rat, mouse and rabbit brain. We could not detect transcripts in other non-muscle tissues.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340214     DOI: 10.1038/331635a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Hexose transport in human myoblasts.

Authors:  O T Mesmer; T C Lo
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution.

Authors:  S Bar; E Barnea; Z Levy; S Neuman; D Yaffe; U Nudel
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Stability of the human dystrophin transcript in muscle.

Authors:  C N Tennyson; Q Shi; R G Worton
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

4.  Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene.

Authors:  H J Klamut; S B Gangopadhyay; R G Worton; P N Ray
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

5.  Dystrophin deficiency in a case of congenital myopathy.

Authors:  A Prelle; R Medori; M Moggio; H W Chan; A Gallanti; G Scarlato; E Bonilla
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

Review 6.  Normal and altered pre-mRNA processing in the DMD gene.

Authors:  Sylvie Tuffery-Giraud; Julie Miro; Michel Koenig; Mireille Claustres
Journal:  Hum Genet       Date:  2017-06-09       Impact factor: 4.132

7.  Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients.

Authors:  A F Miranda; E Bonilla; G Martucci; C T Moraes; A P Hays; S Dimauro
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

8.  Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues.

Authors:  J P Hugnot; H Gilgenkrantz; N Vincent; P Chafey; G E Morris; A P Monaco; Y Berwald-Netter; A Koulakoff; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 9.  Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Authors:  Sasha Bogdanovich; Kelly J Perkins; Thomas O B Krag; Tejvir S Khurana
Journal:  J Mol Med (Berl)       Date:  2003-12-12       Impact factor: 4.599

10.  Duchenne muscular dystrophy and dystrophin: sequence homology observations.

Authors:  A D Gurusinghe; M C Wilce; L Austin; M T Hearn
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.